SEP 15·SEC EDGARLow
BJERKHOLT ERIC sold $978K of MIRM
BJERKHOLT ERIC (CHIEF FINANCIAL OFFICER) sold 9,943 shares of Mirum Pharmaceuticals, Inc. (MIRM) at $98.37 ($0.98M total) on 2026-09-14.
StockNASDAQ · US · USDHealthcare · Biotechnology
$MIRM
Mirum Pharmaceuticals, Inc.
Price · $MIRMvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $MIRM in the last 7 days.
Insider · 30dAll trades →
- Buys
- — 0 txs
- Sells
- $8.0M 5 txs
Peetz Christopher2× · $3.0M
10b5-1 share of filings60%
Top stories · $MIRMMore →
SEP 8·SEC EDGAR 8-K
Mirum Pharmaceuticals, Inc. (MIRM): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Mirum Pharmaceuticals, Inc. (MIRM) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 8, 2026, Mirum Pharmaceuticals, Inc. (the “Company”) announced that, on September 2, 2026, the Company’s Board
SEP 3·SEC EDGAR
Peetz Christopher sold $3.0M of MIRM
Peetz Christopher (CHIEF EXECUTIVE OFFICER) sold 30,000 shares of Mirum Pharmaceuticals, Inc. (MIRM) at an average of $98.68 ($98.08–$98.91, $2.96M total) across 2 trades on 2026-09-01 under a Rule 10b5-1 trading plan.
MIRM sentiment & insider activity
Recent MIRM coverage spans insider activity, corporate actions and earnings.
In the last 30 days, MIRM insiders filed 5 SEC Form 4 transactions — no purchases and 5 sales ($8.0M). The most active reporter was Peetz Christopher, CHIEF EXECUTIVE OFFICER, with 2 filings. 60% of those filings were made under pre-arranged Rule 10b5-1 plans.
What's driving MIRM
The insider sale may signal reduced confidence and could exert slight downward pressure on the stock.
Executive turnover may affect short‑term sentiment and stock volatility.
Insider sale may signal reduced confidence, but size is modest relative to holdings.
Insider sale may signal negative sentiment, but size is modest relative to market cap.
This is an insider sale disclosure, not a fundamental update, but it can still affect near-term sentiment and positioning.
AlphAI scores every news story that mentions MIRM with an AI model for sentiment and relevance, and aggregates insider trades from Mirum Pharmaceuticals, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $MIRM
Score
BJERKHOLT ERIC sold $978K of MIRM
BJERKHOLT ERIC (CHIEF FINANCIAL OFFICER) sold 9,943 shares of Mirum Pharmaceuticals, Inc. (MIRM) at $98.37 ($0.98M total) on 2026-09-14.
1 min readMirum Pharmaceuticals, Inc. (MIRM): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Mirum Pharmaceuticals, Inc. (MIRM) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 8, 2026, Mirum Pharmaceuticals, Inc. (the “Company”) announced that, on September 2, 2026, the Company’s Board
1 min readPeetz Christopher sold $3.0M of MIRM
Peetz Christopher (CHIEF EXECUTIVE OFFICER) sold 30,000 shares of Mirum Pharmaceuticals, Inc. (MIRM) at an average of $98.68 ($98.08–$98.91, $2.96M total) across 2 trades on 2026-09-01 under a Rule 10b5-1 trading plan.
1 min readHowe Jolanda sold $4.0M of MIRM
Howe Jolanda (SVP, GLOBAL CONTROLLER) sold 40,000 shares of Mirum Pharmaceuticals, Inc. (MIRM) at $100.00 ($4.00M total) on 2026-08-18.
1 min readBJERKHOLT ERIC sold $600K of MIRM
BJERKHOLT ERIC (CHIEF FINANCIAL OFFICER) sold 6,001 shares of Mirum Pharmaceuticals, Inc. (MIRM) at $99.90 ($0.60M total) on 2026-08-11 under a Rule 10b5-1 trading plan.
2 min readPeetz Christopher sold $2.0M of MIRM
Peetz Christopher (CHIEF EXECUTIVE OFFICER) sold 20,000 shares of Mirum Pharmaceuticals, Inc. (MIRM) at an average of $98.92 ($98.51–$100.14, $1.98M total) across 3 trades on 2026-08-10 under a Rule 10b5-1 trading plan.
1 min readMirum Pharmaceuticals, Inc. (MIRM): Results of Operations and Financial Condition
Mirum Pharmaceuticals, Inc. (MIRM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Mirum Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update – Q2 2026 net product sales of $176 million – 2026 net product sales guidance increased to $680 million to $700 million – Volixibat granted Breakthrough Therapy and Orpha
6 min readPeetz Christopher sold $2.4M of MIRM
Peetz Christopher (CHIEF EXECUTIVE OFFICER) sold 20,000 shares of Mirum Pharmaceuticals, Inc. (MIRM) at an average of $122.27 ($121.65–$124.79, $2.45M total) across 4 trades on 2026-07-06 under a Rule 10b5-1 trading plan.
1 min readBJERKHOLT ERIC sold $611K of MIRM
BJERKHOLT ERIC (CHIEF FINANCIAL OFFICER) sold 5,000 shares of Mirum Pharmaceuticals, Inc. (MIRM) at an average of $122.25 ($121.67–$124.94, $0.61M total) across 4 trades on 2026-07-06 under a Rule 10b5-1 trading plan.
1 min readMirum Pharmaceuticals, Inc. (MIRM): Submission of Matters to a Vote of Security Holders
Mirum Pharmaceuticals, Inc. (MIRM) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. 8-K false 0001759425 0001759425 2026-06-15 2026-06-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 15,
2 min read